{"id":11477,"date":"2020-04-13T17:43:34","date_gmt":"2020-04-13T21:43:34","guid":{"rendered":"https:\/\/cahr.wpengine.com\/?post_type=virtual_conferences&p=11477"},"modified":"2020-05-07T13:11:08","modified_gmt":"2020-05-07T17:11:08","slug":"affiches","status":"publish","type":"virtual_conferences","link":"https:\/\/www.cahr-acrv.ca\/fr\/virtual_conferences\/affiches\/","title":{"rendered":"Affiches"},"content":{"rendered":"

\"\"<\/p>\n

Affiches \u00e9lectroniques<\/strong><\/h4>\n

Cliquez sur le titre du r\u00e9sum\u00e9 pour voir la pr\u00e9sentation de l’affiche \u00e9lectronique.<\/p>\n

SCIENCES FONDAMENTALES<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
BS1.02<\/td>\nCharacterization of Gag mutations in HIV-1 subtype A long-term non-progressors<\/a><\/td>\n<\/tr>\n
BS1.03<\/td>\nRates and Patterns of Indels in HIV-1 gp120 Within Hosts<\/a><\/td>\n<\/tr>\n
BS1.04<\/td>\nPan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking<\/a><\/td>\n<\/tr>\n
BS1.05<\/td>\nART-treated adults with diagnosed atherosclerosis are characterized by a particular expression of Regulatory T-cells<\/a><\/td>\n<\/tr>\n
BS2.04<\/td>\nGenetic diversity of HIV proviruses persisting during cART in former viremic controllers<\/a><\/td>\n<\/tr>\n
BS2.06<\/td>\nStaphylococcus aureus and Candida albicans Facilitate HIV Reservoir Establishment in CD4+ T-Cells by Promoting RALDH Activity in Dendritic Cells<\/a><\/td>\n<\/tr>\n
BS2.07<\/td>\nPersistent HIV Reservoir Suppression by (-)-Hopeaphenol, a Plant-Derived Stilbenoid<\/a><\/td>\n<\/tr>\n
BS3.04<\/td>\nDevelopment of an HIV Vaccine Component Based on Carbohydrate Mimicry<\/a><\/td>\n<\/tr>\n
BS3.06<\/td>\nBreg Function of Marginal Zone Precursor B-cells is Modulated by BAFF-expressing Dendritic Cells<\/a><\/td>\n<\/tr>\n
BS3.07<\/td>\nEpigenetic control of human regulatory T cells (Tregs) during HIV-1 infection<\/a><\/td>\n<\/tr>\n
BS4.04<\/td>\nHumanized Mice for Studying HIV Persistence in Long-lived Tissue-resident Macrophages<\/a><\/td>\n<\/tr>\n
BSP1.03<\/td>\nCharacterization of the Role of Host Cell Decapping Activators DDX6, LSm1-7 and PatL1 in HIV-1 Replication<\/a><\/td>\n<\/tr>\n
BSP1.04<\/td>\nImpact of in vitro HIV Infection and TGF-\u03b2 Stimulation on Human Thymic Regulatory T-cell Development<\/a><\/td>\n<\/tr>\n
BSP1.05<\/td>\nThe Use of Aspirin to Reduce Inflammation Does Not Adversely Affect Systemic T Regulatory Cells<\/a><\/td>\n<\/tr>\n
BSP1.07<\/td>\nCharacterization of a G118K plus R263K combination of integrase resistance mutations associated with HIV viral load rebound in a patient failing dolutegravir-based therapy<\/a><\/td>\n<\/tr>\n
BSP1.08<\/td>\nA complex interplay between the HIV-1 Env gp120 inner domain and the Phe43 cavity shapes the CD4-binding site<\/a><\/td>\n<\/tr>\n
BSP1.09<\/td>\nInvestigation of Integrase Inhibitor Resistance Mutations in gp41 in Clinical Samples<\/a><\/td>\n<\/tr>\n
BSP1.11<\/td>\nAnti-HIV activity of the human antimicrobial peptide, LL-37, and its truncated peptide, 17BIPHE2<\/a><\/td>\n<\/tr>\n
BSP2.02<\/td>\nHIV-1 Infection Disrupts Circadian Patterns of Extracellular Vesicles Abundance and microRNA Contents<\/a><\/td>\n<\/tr>\n
BSP2.03<\/td>\nValidity of Dried Blood Spot Testing for Sexually Transmitted and Blood Borne Infections: A Systematic Review<\/a><\/td>\n<\/tr>\n
BSP2.04<\/td>\nDaily Variations of Gut Microbial Translocation Markers in ART-treated People Living with HIV<\/a><\/td>\n<\/tr>\n
BSP5.01<\/td>\nThe Circadian Clock Machinery Regulates HIV Transcription in CD4+ T cells<\/a><\/td>\n<\/tr>\n
BSP5.02<\/td>\nThe Efficacity of DCIR Inhibitors to Limit HIV-1 Infection<\/a><\/td>\n<\/tr>\n
BSP6.01<\/td>\nValidation of integration date estimation methods using a simulation of HIV latent genomes<\/a><\/td>\n<\/tr>\n
BSP6.02<\/td>\nHIV Diversity Considerations in the Application of the Intact Proviral Detection Assay (IPDA)<\/a><\/td>\n<\/tr>\n
BSP6.03<\/td>\nA case of super-infection with two highly divergent HIV-1 strains: implications for the latent reservoir<\/a><\/td>\n<\/tr>\n
BSP6.04<\/td>\nThe Characterizing and Understanding the HIV Reservoir for Eradication (CURE) Cohort: a New Resource for Understanding HIV Persistence<\/a><\/td>\n<\/tr>\n
BSP6.05<\/td>\nEffect of Thymic Output on the Homeostasis of the HIV Reservoir<\/a><\/td>\n<\/tr>\n
BSP7.01<\/td>\nDaily Immunological\/Virological Variations in Aviremic ART-treated HIV Participants<\/a><\/td>\n<\/tr>\n
BSP8.01<\/td>\nNew tools to study the expression of the Antisense Protein gene in the proviral DNA context<\/a><\/td>\n<\/tr>\n
BSP8.02<\/td>\nIFITM3 and SERINC5 Exert Distinct Inhibitory Pressures on HIV-1 Env Over the Course of Viral Infection<\/a><\/td>\n<\/tr>\n
BSP8.06<\/td>\nGenotyping of HIV-1 isolates infecting children and adolescents with undetectable viral load under antiretroviral therapy<\/a><\/td>\n<\/tr>\n
BSP8.08<\/td>\nHIV-1 Vpu Downregulates Tim-3 from the Surface of Infected CD4+ T Cells<\/a><\/td>\n<\/tr>\n
BSP8.12<\/td>\nPseudotyping the Oncolytic Virus MG1 to Enhance Its Ability to Selectively Kill HIV Infected Cells<\/a><\/td>\n<\/tr>\n
BSP8.13<\/td>\nA Previously Unidentified Residue Within the Dileucine Motif is Required for HIV-1 Nef Antagonism of the SERINC5 Restriction Factor<\/a><\/td>\n<\/tr>\n
BSP8.14<\/td>\nR5 HIV-1 preferentially translocates across genital mucosa while X4 virus is selectively sequestered inside genital epithelial cells and activates Type I IFN signalling<\/a><\/td>\n<\/tr>\n
BSP8.16<\/td>\nModulation of the human nuclear pore complex by HIV-1 and IFN-I<\/a><\/td>\n<\/tr>\n
BSP9.01<\/td>\nCaract\u00e9risation des monocytes du sang circulant chez des travailleuses du sexe b\u00e9ninoises dans le contexte du VIH<\/a><\/td>\n<\/tr>\n
BSP9.02<\/td>\nAssociations of Host Genetic Variation with Regulation of Inflammatory Gene Expression and HIV Susceptibility<\/a><\/td>\n<\/tr>\n
BSP9.03<\/td>\nHost Genetic Regulation of HIV Set-Point Viral Load in Individuals of African Ancestry<\/a><\/td>\n<\/tr>\n
BSP10.04<\/td>\nLAG-3 and PD-1 blocking synergizes to restore invariant Natural Killer T Cell Functionality: Implications for HIV treatment<\/a><\/td>\n<\/tr>\n
BSP10.05<\/td>\nPhenotype and Cytokine Expression of Peripheral and Gut-derived \u03b3\u03b4 T Cell Subsets from HAART-treated HIV+ Individuals and Healthy Controls<\/a><\/td>\n<\/tr>\n
BSP10.07<\/td>\nFunctional and structural determinants of T-cell receptor-mediated control of HIV<\/a><\/td>\n<\/tr>\n
BSP10.08<\/td>\nInterplay between IL-32 and CD96 expression: potential role in cell senescence and persistent inflammation in HIV infection<\/a><\/td>\n<\/tr>\n
BSP10.09<\/td>\nImpact of cumulative proportion of life under sustained viral suppression on HIV-specific immune responses and T cell exhaustion in children and adolescents with perinatally-acquired HIV infection<\/a><\/td>\n<\/tr>\n
BSP10.10<\/td>\nBAFF\/BLyS est impliqu\u00e9 dans la modulation du ph\u00e9notype Breg des lymphocytes B de la zone marginale<\/a><\/td>\n<\/tr>\n
BSP10.11<\/td>\nDetecting LAG3: antibody discrepancies in flow cytometry<\/a><\/td>\n<\/tr>\n
BSP10.12<\/td>\nImplications of long-term solvent use on NK activation and function: a risk factor for HIV Acquisition<\/a><\/td>\n<\/tr>\n
BSP10.14<\/td>\nAspirin Use Impacts T Cell Trafficking and Correlates with Lower HIV Target Cells at the Genital Mucosa<\/a><\/td>\n<\/tr>\n
BSP11.01<\/td>\nPhylodynamics of HCV Genotypes 3a and 1a in Pakistan<\/a><\/td>\n<\/tr>\n
BSP11.02<\/td>\nDrug Efflux Transporters and Drug Metabolic Enzymes in Human Circulating and Testicular T-cell Subsets: Relevance to HIV Pharmacotherapy<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

SCIENCES CLINIQUES<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
CS1.03<\/td>\nRisk Factors for Small for Gestational Age and Microcephaly among HIV-Exposed Infants in Montreal, Quebec, Canada<\/a><\/td>\n<\/tr>\n
CS1.04<\/td>\nAssessing the Cellular and Mitochondrial Effects of Integrase Inhibitors in a Human Embryonic Stem Cell Model<\/a><\/td>\n<\/tr>\n
CS1.06<\/td>\nBreastfeeding by Women Living with HIV in a Resource-Rich Setting: A Multicenter Retrospective Review of Maternal and Infant Management and Outcomes<\/a><\/td>\n<\/tr>\n
CS2.01<\/td>\nSuccessful Aging with HIV: Who and How?<\/a><\/td>\n<\/tr>\n
CS2.02<\/td>\nMetformin Decreases Weight and Inflammation in Non-Diabetic People Living with HIV: Link with Microbiota Composition<\/a><\/td>\n<\/tr>\n
CS2.03<\/td>\nPilot Randomized Controlled Trial to Determine the Feasibility and Acceptability of Group Therapy for People Aging with HIV Facing Cognitive Challenges<\/a><\/td>\n<\/tr>\n
CS2.04<\/td>\nFrailty is a Unique Entity for People Living with HIV<\/a><\/td>\n<\/tr>\n
CS2.05<\/td>\nPrevalence, Predictors and Evolution of Lean Non-alcoholic Fatty Liver Disease in HIV Mono-infected Patients<\/a><\/td>\n<\/tr>\n
CS2.06<\/td>\nIncidence of Diabetes Mellitus Among People Living with HIV Compared with HIV Negative Individuals in British Columbia Between 2001-2013<\/a><\/td>\n<\/tr>\n
CS2.07<\/td>\nExamining the Utility of the HIV Disability Questionnaire (HDQ) in Clinical Practice: Perspectives of Adults Aging with HIV and Health Care Providers<\/a><\/td>\n<\/tr>\n
CS3.01<\/td>\nEffectiveness and Safety of Bictegravir\/Emtricitabine\/Tenofovir Alafenamide (B\/F\/TAF in Canadians Living with HIV; the BICSTaR Cohort<\/a><\/td>\n<\/tr>\n
CS3.06<\/td>\nA Clinically-derived HIV Integrase Sequence Harboring High Levels of Genotypic and Phenotypic Resistance to Integrase Strand Transfer Inhibitors<\/a><\/td>\n<\/tr>\n
CS3.08<\/td>\nDolutegravir-containing HIV therapies appear to increase cellular apoptosis and mitochondrial toxicities in human PBMCs<\/a><\/td>\n<\/tr>\n
CS4.04<\/td>\nThe HPV Screening and Vaccine Evaluation (HPV-SAVE) Study: Risk Behaviours and Anal Dysplasia in MSM Living with HIV<\/a><\/td>\n<\/tr>\n
CS4.05<\/td>\nIdentifying Intersectional Gaps in Secondary Mental Health Service Use in the Ontario HIV Treatment Network Cohort Study (OCS)<\/a><\/td>\n<\/tr>\n
CS4.06<\/td>\nThe relationship between inflammatory biomarkers and CD4 count decline during antiretroviral-untreated HIV: A substudy of the VALIDATE (CTN-240) trial<\/a><\/td>\n<\/tr>\n
CSP1.01<\/td>\nChatbot MARVIN: Development study of an Intelligent Conversational Agent to Promote HIV Patients\u2019 Engagement in Care and Management of ART Adherence Barriers<\/a><\/td>\n<\/tr>\n
CSP2.01<\/td>\nIntegrase Inhibitor Exposure is Linked to Neurocognitive Deficits in HIV<\/a><\/td>\n<\/tr>\n
CSP2.02<\/td>\nLong\u2010term Efficacy and Safety of Bictegravir\/Emtricitabine\/Tenofovir Alafenamide (B\/F\/TAF) in ART\u2010Na\u00efve Adults<\/a><\/td>\n<\/tr>\n
CSP2.03<\/td>\nDual Therapy with Boosted Darunavir and Dolutegravir: a Review of the Literature<\/a><\/td>\n<\/tr>\n
CSP2.05<\/td>\nChanges in Liver Steatosis, Body Mass Index and Hepatocyte Apoptosis After Switch to Raltegravir<\/a><\/td>\n<\/tr>\n
CSP2.07<\/td>\nNeurodevelopment of HIV\/ARV-Exposed Uninfected Children Compared with HIV-unexposed Uninfected Children During Early Childhood<\/a><\/td>\n<\/tr>\n
CSP3.01<\/td>\nAttitudes Towards Anal Cancer and Screening among Men Who Have Sex with Men Living with HIV: Preliminary Results from the HPV-SAVE Study<\/a><\/td>\n<\/tr>\n
CSP3.03<\/td>\nRelevance of CMV and EBV Co-Infection to Chronic Inflammation in HIV Elite Controllers<\/a><\/td>\n<\/tr>\n
CSP3.04<\/td>\nDifferences in Surveillance for HCC in HIV-Infected Patients with and Without HCV\/HBV Coinfection: Insights from the LIVEHIV Cohort<\/a><\/td>\n<\/tr>\n
CSP4.01<\/td>\nDolutegravir-containing ART Regimens are Not Independently Associated with Weight Changes among British Columbians Living with HIV<\/a><\/td>\n<\/tr>\n
CSP5.01<\/td>\nRelationship Between Hypertension and Incidence of Diabetes Mellitus Among People Living with HIV in British Columbia Between 2001-2013<\/a><\/td>\n<\/tr>\n
CSP5.02<\/td>\n\u00ab\u00a0I have more bad days but the good days are coming\u00a0\u00bb – Pain Experienced Among People Living with HIV Accessing Physiotherapy in a Day Health Program<\/a><\/td>\n<\/tr>\n
CSP5.03<\/td>\nMicrobial Translocation of Fungal \u03b2-D-Glucan is Associated with Cardiovascular Risk in People Living with HIV<\/a><\/td>\n<\/tr>\n
CSP5.04<\/td>\nCardiopulmonary Fitness Changes across a Three-Phased Community-Based Exercise Intervention Study among Adults Living with HIV<\/a><\/td>\n<\/tr>\n
CSP5.05<\/td>\nThe Feasibility and Impact of a Yoga Intervention on Cognitive and Physical Function Among People Living with HIV: a Pilot Randomized Controlled Trial<\/a><\/td>\n<\/tr>\n
CSP6.01<\/td>\nAssessing Antiretroviral Therapy Interruptions at Release from Provincial Correctional Centres to the Community in British Columbia (BC)<\/a><\/td>\n<\/tr>\n
CSP6.03<\/td>\nHIV Treatment Outcomes, Barriers, and Facilitators Among Refugees in British Columbia (BC)<\/a><\/td>\n<\/tr>\n
CSP7.01<\/td>\nVariation of CD4 count in Pregnant Women Living with HIV<\/a><\/td>\n<\/tr>\n
CSP7.02<\/td>\nPotential Interaction Between Dolutegravir and Folate Transporters in First Trimester Human Trophoblast Cell Lines<\/a><\/td>\n<\/tr>\n
CSP7.03<\/td>\nAssessing Gaps in Comprehensive HIV Care Across a Typology of Care for Women Living with HIV in Canada<\/a><\/td>\n<\/tr>\n
CSP7.04<\/td>\nImpact of In-utero Exposure to Protease Inhibitor-Based Antiretroviral Drug Regimens on Developmental Milestones in Mice<\/a><\/td>\n<\/tr>\n
CSP7.05<\/td>\nMaternal and Cord Plasma Bioactive Eicosanoid Profiles Differ Between Pregnant Women Living with HIV on Protease Inhibitor Based-ART and HIV-Negative Pregnant Women<\/a><\/td>\n<\/tr>\n
CSP7.06<\/td>\nPatterns of Changing Reproductive Intentions Among Women Living with HIV in Canada<\/a><\/td>\n<\/tr>\n
CSP7.07<\/td>\nAge at Menopause in Women Living with HIV (WLWH): a Systematic Review<\/a><\/td>\n<\/tr>\n
CSP8.01<\/td>\nAn Innovative Training Program to Increase the Competencies of British Columbia\u2019s (BC) Nurse Practitioners (NPs) in HIV Prevention<\/a><\/td>\n<\/tr>\n
CSP8.02<\/td>\nLonger Term Safety of F\/TAF and F\/TDF for HIV PREP: DISCOVER Trial Week 96 Results<\/a><\/td>\n<\/tr>\n
CSP8.04<\/td>\nMental Health and Substance Use Screening Practices among Clients Accessing HIV Testing and Other Sexual Health Services: A Scoping Review<\/a><\/td>\n<\/tr>\n
CSP9.01<\/td>\nDepression, dissatisfaction with sleep and cognitive difficulties interfere with work productivity in the Positive Brain Health Now (BHN) study<\/a><\/td>\n<\/tr>\n
CSP9.02<\/td>\nA Combination of Anxiety, Depression and Associated Symptoms Explains Function Better Than Mood-specific Measures in the Brain Health Now (BHN) Cohort<\/a><\/td>\n<\/tr>\n
CSP10.01<\/td>\nEvaluation of Streamlined HIV Pharmacy Services in a Hospital Based Ambulatory Pharmacy in British Columbia (BC)<\/a><\/td>\n<\/tr>\n
CSP10.02<\/td>\nClosing the Gap! Implementing Physiotherapy in an Interdisciplinary HIV Community-Based Care Setting – A Pilot Evaluation<\/a><\/td>\n<\/tr>\n
CSP10.03<\/td>\n‘It Shows We Care About Those Issues’: an HIV Patients’ and Care Providers’ Qualitative Needs Assessment for a Smart Patient Portal (Opal)<\/a><\/td>\n<\/tr>\n
CSP10.04<\/td>\nThinking Outside the Box: Evaluating a Virtual Classroom Model to Deliver HIV Primary Care Education to Physicians and Nurse Practitioners Across Saskatchewan<\/a><\/td>\n<\/tr>\n
CSP10.05<\/td>\nDisability Experiences and Resilience Strategies of South Asian Women Living with HIV in Southern Ontario<\/a><\/td>\n<\/tr>\n
CSP11.01<\/td>\nAssociation between Untimed Plasma Atazanavir Levels and Renal- or Gallstones<\/a><\/td>\n<\/tr>\n
CSP12.01<\/td>\nEfficacy of Integrase Inhibitor and Protease Inhibitor-based Three Drug Regimens in the Presence of the M184V\/I Mutation: a Review of the Literature<\/a><\/td>\n<\/tr>\n
CSP12.02<\/td>\nSustained Viral Suppression Among Participants with Pre\u2010existing M184V\/I Who Switched to Bictegravir\/Emtricitabine\/Tenofovir Alafenamide<\/a><\/td>\n<\/tr>\n
CSP13.01<\/td>\nComparing HIRI-MSM Scores and New STI Diagnosis in PrEP patient follow-up<\/a><\/td>\n<\/tr>\n
CSP13.02<\/td>\nThe Dual Daily HIV and Syphilis Pre-Exposure Prophylaxis (DuDHS) Trial: Characteristics of Men who have Sex with Men Interested in Combined HIV and Syphilis PrEP.<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

\u00c9PID\u00c9MIOLOGIE ET SIENCES DE LA SANT\u00c9 PUBLIQUE<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
EPH1.04<\/td>\nIncidence of HCV Infection Among gbMSM in British Columbia, Canada: a Population-based Cohort Study<\/a><\/td>\n<\/tr>\n
EPH1.06<\/td>\nIs hepatitis C elimination sustainable in populations with ongoing transmission risk? Modelling post-elimination epidemics among people who inject drugs<\/a><\/td>\n<\/tr>\n
EPH2.04<\/td>\nNeighbourhood Level Material Deprivation and Complete Immune Response (VL+\/CD4+) in the Canadian HIV+ Observational Cohort Collaboration (CANOC)<\/a><\/td>\n<\/tr>\n
EPH2.06<\/td>\nPrevalence of and Factors Associated with Syphilis among Gay, Bisexual and Other Men Who Have Sex with Men (GBM) in Montreal, Toronto and Vancouver: Results from the Engage Study<\/a><\/td>\n<\/tr>\n
EPH2.08<\/td>\nIncidence rates for oral cavity and oropharyngeal cancers among HIV-positive and HIV-negative individuals in British Columbia: a retrospective cohort study<\/a><\/td>\n<\/tr>\n
EPH3.04<\/td>\nHIV Acquisition among Federal Offenders in Canada 2005-2018<\/a><\/td>\n<\/tr>\n
EPH3.06<\/td>\nHIV-Related Complications and Overdose are Primary Drivers of Mortality Among Women Living with HIV in the Modern Treatment Era<\/a><\/td>\n<\/tr>\n
EPH3.07<\/td>\nHIV Prevention and Treatment Cascades Among Female Sex Workers (FSW) and Men Who Have Sex with Other Men (MSM) in Benin, West Africa<\/a><\/td>\n<\/tr>\n
EPH4.01<\/td>\nDeveloping a Predictive Index for HIV Pre-exposure Prophylaxis (PrEP) Use among Gay, Bisexual and Other men Who Have Sex with Men<\/a><\/td>\n<\/tr>\n
EPH4.04<\/td>\nPopulation-Based HIV Pre-Exposure Prophylaxis (PrEP) in British Columbia (BC): an 18-Month Update on Client Enrollment and Prescriber Participation<\/a><\/td>\n<\/tr>\n
EPHP1.01<\/td>\nThe Canadian Network on Hepatitis C (CanHepC) Virtual Cascade of Care Cohort (VCCC) Feasibility Study \u2013 SK Component<\/a><\/td>\n<\/tr>\n
EPHP1.02<\/td>\nAn outcome-based statistical framework to select and optimize molecular clustering methods for infectious diseases.<\/a><\/td>\n<\/tr>\n
EPHP1.03<\/td>\nThe incidence of anal squamous cell carcinoma in a cohort of HIV-positive and HIV-negative individuals in British Columbia, Canada (1990-2015)<\/a><\/td>\n<\/tr>\n
EPHP1.04<\/td>\nFuture and Existing Trials Have Information to Identify Frailty<\/a><\/td>\n<\/tr>\n
EPHP1.05<\/td>\nA Cohort-based Study of Models of Primary Care Among Marginalized People Who Use Drugs in Ottawa, Canada<\/a><\/td>\n<\/tr>\n
EPHP1.07<\/td>\nExamining HIV transmission clusters among newly-diagnosed asylum seekers in Montreal, Quebec<\/a><\/td>\n<\/tr>\n
EPHP1.08<\/td>\nCascades of Care for Preventing Vertical HIV Transmission<\/a><\/td>\n<\/tr>\n
EPHP1.10<\/td>\nContext is Everything: a Recommendation for Selecting Case Definitions when Using Linked Administrative Health Data in HIV Research<\/a><\/td>\n<\/tr>\n
EPHP1.11<\/td>\nValidating the use of viral load results to identify individuals with prior evidence of HIV, Ontario, 2018<\/a><\/td>\n<\/tr>\n
EPHP1.12<\/td>\nTrends in HIV Pre-exposure Prophylaxis (PrEP) Use in Canada, 2014\u20132018<\/a><\/td>\n<\/tr>\n
EPHP1.13<\/td>\nVirologic Outcome Measures in HIV Clinical Trials: a Methodological Study<\/a><\/td>\n<\/tr>\n
EPHP2.01<\/td>\nBringing Language specific communities to Toronto to Zero \u2015There is a need for a NEW campaign (digital intervention) for GB&MSM Latino Men (e.g., PrEP, U=U), GUYS LIKE YOU 2020?<\/a><\/td>\n<\/tr>\n
EPHP3.01<\/td>\nA cross-sectional study of prolonged disengagement from clinic among people with HCV receiving care in a low threshold, multidisciplinary clinic<\/a><\/td>\n<\/tr>\n
EPHP3.02<\/td>\nIncident Hepatitis C Virus Infection among Gay, Bisexual, and other men who have sex with men in Metro Vancouver: A Prospective Biobehavioural Cohort Study<\/a><\/td>\n<\/tr>\n
EPHP3.03<\/td>\nPreliminary Findings from Per-SVR, a Longitudinal Cohort of Hepatitis C Patients Who Achieved Sustained Virologic Response<\/a><\/td>\n<\/tr>\n
EPHP3.04<\/td>\nPredicting the Presence of Clinically Significant Depressive Symptoms in the HIV-Hepatitis C Co-infected Population in Canada using Supervised Machine Learning<\/a><\/td>\n<\/tr>\n
EPHP3.05<\/td>\nMultiplexed Technologies for Sexually Transmitted Infections: A Systematic Review of Global Evidence on Feasibility, Seropositivity and Impact Outcomes<\/a><\/td>\n<\/tr>\n
EPHP3.06<\/td>\nThe validation of a novel deprivation index for co-infected individuals with non-attendance of a second visit<\/a><\/td>\n<\/tr>\n
EPHP3.07<\/td>\nPerinatal and Obstetrical Outcomes in HIV Mono-Infection and HIV\/Hepatitis C Co-Infection<\/a><\/td>\n<\/tr>\n
EPHP3.08<\/td>\nHIV Screening and Co-infection Among Persons Diagnosed with Active Tuberculosis in British Columbia, 2009-2018<\/a><\/td>\n<\/tr>\n
EPHP4.01<\/td>\nMANDALAS – \u201cColoring Connections\u201d-An Art therapy group & mental health HIV +\/- individuals in Toronto: Social Disconnection a common tale in the HIV Prevention Program, CSSP<\/a><\/td>\n<\/tr>\n
EPHP4.02<\/td>\nTrans Latinas Ontario (TLO):\u00a0 4 Years of Empowering HIV+\/at risk Transwomen at the HIV Prevention Program of the Centre for the Spanish-Speaking Peoples (CSSP)<\/a><\/td>\n<\/tr>\n
EPHP4.03<\/td>\nCan\u2019t Pass it On: Evaluation of a Pan-Canadian U=U Awareness Campaign<\/a><\/td>\n<\/tr>\n
EPHP4.04<\/td>\n\u201cFib-4 First\u201d Risk-stratification Model in a NAFLD Assessment Pathway for HIV Mono-infected Patients<\/a><\/td>\n<\/tr>\n
EPHP4.05<\/td>\nTrends in Knowledge of HIV Status and Efficiency of Testing Programs in Sub-Saharan Africa (2000-2018): a Modeling Study of Survey and HIV Testing Program Data<\/a><\/td>\n<\/tr>\n
EPHP4.06<\/td>\nImpact of Screening Criteria for Tenofovir Alafenamide Eligibility in the BC Centre for Excellence in HIV\/AIDS (BC-CfE) Drug Treatment Program (DTP)<\/a><\/td>\n<\/tr>\n
EPHP4.07<\/td>\nComparing PrEP Accessibility and Users in Mid- and Large-sized Urban Centres<\/a><\/td>\n<\/tr>\n
EPHP4.08<\/td>\nAn Epidemiological Model for HIV Self-Testing in Canada<\/a><\/td>\n<\/tr>\n
EPHP4.09<\/td>\nEvaluating HIV Rapid\/Point of Care Testing Positive Predictive Value among Risk Factor Groups in Ontario, 2011-2018<\/a><\/td>\n<\/tr>\n
EPHP4.10<\/td>\nVertical Transmission in Canada: Canadian Perinatal HIV Surveillance Program<\/a><\/td>\n<\/tr>\n
EPHP4.12<\/td>\nGender Differences in HIV Diagnoses in BC<\/a><\/td>\n<\/tr>\n
EPHP5.02<\/td>\nHIV viral load suppression and linked transmission amongst male and female sex workers in the Nairobi Sex Worker Outreach Programme (SWOP)<\/a><\/td>\n<\/tr>\n
EPHP5.04<\/td>\nStandardized Mortality Ratio among Street-Connected Youth with a High Burden of HIV in an Urban Setting in Sub-Saharan Africa<\/a><\/td>\n<\/tr>\n
EPHP5.05<\/td>\nAwareness and Uptake of HIV Pre-exposure Prophylaxis Among Gay and Other Men Who Have Sex with Men in Ontario<\/a><\/td>\n<\/tr>\n
EPHP5.08<\/td>\nSociodemographic Characteristics of HIV Positive Gay and Other Men who Have Sex with Men in Ontario<\/a><\/td>\n<\/tr>\n
EPHP5.10<\/td>\nDo men who have sex with men in sub-Saharan Africa have lower knowledge of HIV status than the national average for all men? A meta-analysis of estimates in 22 countries<\/a><\/td>\n<\/tr>\n
EPHP5.11<\/td>\nAcc\u00e8s Aux Soins et Services de Sant\u00e9 des PVVIH Issues de L\u2019immigration, Sans Assurance Maladie. Une Revue Narrative Systematique<\/a><\/td>\n<\/tr>\n
EPHP5.12<\/td>\nHIV 90-90-90 targets and the care continuum: findings from the Tracks survey among people who inject drugs in Canada, Phase 4 (2017-2019)<\/a><\/td>\n<\/tr>\n
EPHP6.02<\/td>\nCODE BLUE! CODE BLUE! Spanish-Speaking gbMSMindividuals in Canada and HIV, a language ethno-specific population need, in a Canadian HIV to Zero strategy \u2015ESTAMOS AQUI!<\/a><\/td>\n<\/tr>\n
EPHP6.04<\/td>\nReasons for Declining PrEP Referrals among Gay, Bisexual and Other Men Who Have Sex With Men (gbMSM) at PRIMP study Implementation Sites in Toronto<\/a><\/td>\n<\/tr>\n
EPHP6.05<\/td>\nOperational Diversity Among Clinics in the PRIMP Study on Scaling Up PrEP Implementation for gbMSM in British Columbia and Ontario<\/a><\/td>\n<\/tr>\n
EPHP6.06<\/td>\nChanging demographic and HIV risk behaviors of clients of female sex workers in Karnataka, India<\/a><\/td>\n<\/tr>\n
EPHP6.07<\/td>\nAddressing and Responding to Needs of People Living with HIV in the Montreal Region Without Healthcare Coverage<\/a><\/td>\n<\/tr>\n
EPHP6.09<\/td>\nUsing the Theoretical Domains Framework to identify barriers and facilitators for PrEP implementation in Colombia – The PrEP-Col Study<\/a><\/td>\n<\/tr>\n
EPHP6.10<\/td>\nPredictors of Intention to Provide PrEP in Health-care Workers in HIV Clinics in Colombia: Application of the Theoretical Domain Framework – The PrEP Col Study<\/a><\/td>\n<\/tr>\n
EPHP6.11<\/td>\nInforming the path towards HIV elimination in Montreal among men who have sex with men through HIV combination prevention: a mathematical modelling approach<\/a><\/td>\n<\/tr>\n
EPHP6.12<\/td>\nCharacteristics of the HIV cascade of care and unsuppressed viral load among HIV positive gbMSM across three Canadian cities<\/a><\/td>\n<\/tr>\n
EPHP6.15<\/td>\nHIV Pre-exposure Prophylaxis (PrEP) Adoption in Primary Care: An Online Survey of Ontario Physicians<\/a><\/td>\n<\/tr>\n
EPHP8.01<\/td>\nPartner Notification for Bacterial STIs among Gay, Bisexual and Other Men Who Have Sex with Men (GBM) in Vancouver, Toronto and Montreal: Results from the Engage Study<\/a><\/td>\n<\/tr>\n
EPHP8.02<\/td>\nTowards Disability-informed HIV Screening in the United States: a Cross-sectional Study Examining the Relationship Between Disability and HIV Testing Using NHANES Data<\/a><\/td>\n<\/tr>\n
EPHP8.04<\/td>\nWho is Prescribing PrEP? A Characterization of Ontario Clinicians Prescribing HIV Pre-Exposure Prophylaxis<\/a><\/td>\n<\/tr>\n
EPHP8.05<\/td>\nAttitudinal Factors Associated with Condom use among Heterosexual African Caribbean Black (ACB) Men in Ontario<\/a><\/td>\n<\/tr>\n
EPHP8.06<\/td>\nHIV Services Access Among Men who have Sex with Men (MSM) in the Region of Waterloo: Insights from the OutLook Study<\/a><\/td>\n<\/tr>\n
EPHP8.07<\/td>\nIs Dating App\/Website Use Associated with Sexual Behaviours at Risk for STBBI Transmission? Results from Engage-Montr\u00e9al<\/a><\/td>\n<\/tr>\n
EPHP8.08<\/td>\nA national HIV Testing Strategy: Determining Best Practices and Barriers<\/a><\/td>\n<\/tr>\n
EPHP8.13<\/td>\nAssessing Adherence, Follow-up, and Effectiveness for Patients on HIV Pre-exposure Prophylaxis Outside a Major Urban Centre<\/a><\/td>\n<\/tr>\n
EPHP9.01<\/td>\nChemsex and symptoms of anxiety and depression among gay, bisexual, and other men who have sex with men (GBM) in Montr\u00e9al: Results from the ENGAGE study.<\/a><\/td>\n<\/tr>\n
EPHP9.03<\/td>\nMechanisms in the Relationship Between Crystal Methamphetamine Use and STI Diagnosis and HIV\/STI Risks in Gay, Bisexual, and Other Men Who Have Sex with Men (gbMSM)<\/a><\/td>\n<\/tr>\n
EPHP9.04<\/td>\nTobacco Smoking and Complete Immune Response (VL+\/CD4+) in the Canadian HIV+ Observational Cohort Collaboration (CANOC)<\/a><\/td>\n<\/tr>\n
EPHP10.01<\/td>\nTask-shifting in HIV Testing Services<\/a><\/td>\n<\/tr>\n
EPHP10.02<\/td>\nProgrammatic approaches for successful linkage to HIV care<\/a><\/td>\n<\/tr>\n
EPHP10.03<\/td>\nPractical cognitive rehabilitation strategies to tackle cognitive concerns in people with HIV<\/a><\/td>\n<\/tr>\n
EPHP10.05<\/td>\nCaesarean Sections Among Women Living with HIV: a Population-Based Retrospective Cohort Study<\/a><\/td>\n<\/tr>\n
EPHP11.01<\/td>\nImplementation of Tracks: Survey of determinants of HIV and hepatitis C among Indigenous Peoples in Canada in First Nations Communities in 2019<\/a><\/td>\n<\/tr>\n
EPHP11.03<\/td>\n(Re)Defining Meaningful Engagement with Community: Lessons from a study on racial disparities in health outcomes of MSM living with HIV in a national HIV cohort study<\/a><\/td>\n<\/tr>\n
EPHP11.04<\/td>\nEngaging Older Adults Living with HIV: Training Peer Research Associates in the Implementation of a Community-Based Research Project; PANACHE Ontario Study<\/a><\/td>\n<\/tr>\n
EPHP11.05<\/td>\nOlder People Living with HIV as Peer Research Associates:\u00a0 Reflections on the Role and Experiences; PANACHE Ontario<\/a><\/td>\n<\/tr>\n
CSP9.03<\/td>\nCharacteristics of Individuals with Significant Depressive Symptoms among People Living with HIV in British Columbia<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

SCIENCES SOCIALES<\/h4>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
SS1.01<\/td>\nThe Perils of \u201cProtection\u201d: Sex workers\u2019 experiences of law enforcement in Ontario<\/a><\/td>\n<\/tr>\n
SS1.03<\/td>\nCriminalization of HIV Non-disclosure: another Mechanism of Social and Judicial Surveillance and Control of Black Women Living with HIV in Canada<\/a><\/td>\n<\/tr>\n
SS1.04<\/td>\nNot in THIS backyard: HaliFIX OPS strategies for overcoming NIMBYism<\/a><\/td>\n<\/tr>\n
SS1.05<\/td>\nLessons Learned from Implementing Injectable Opioid Agonist Treatment in an Innovative Community Based Model<\/a><\/td>\n<\/tr>\n
SS1.06<\/td>\nCondom use and HIV criminalisation in Canada<\/a><\/td>\n<\/tr>\n
SS2.04<\/td>\nCapacity Bridging: Establishing Meaningful Collaboration between Peer Researchers and Academic Researchers in the Ontario Implementation of the HIV Stigma Index<\/a><\/td>\n<\/tr>\n
SS2.05<\/td>\nThe Butterfly Project: An Indigenous Community-Based Research, Knowledge Translation Project<\/a><\/td>\n<\/tr>\n
SS2.06<\/td>\nGetting to Zero Manitoba a Collective Impact Approach<\/a><\/td>\n<\/tr>\n
SS2.08<\/td>\nEngaging Communities as Allies in Harm Reduction<\/a><\/td>\n<\/tr>\n
SS3.01<\/td>\nIndex de la stigmatisation des personnes vivant avec le VIH (PVVIH) au Qu\u00e9bec : Intersectionnalit\u00e9 et stigmatisation<\/a><\/td>\n<\/tr>\n
SS3.03<\/td>\nHiv and Improvement in Mental Health Symptoms Among Gay, Bisexual and Other Men Who Have Sex with Men (gbMSM) in Vancouver<\/a><\/td>\n<\/tr>\n
SS3.05<\/td>\nExploring Young, Black Gay, Bisexual and Other Men Who Have Sex with Men\u2019s PrEP Knowledge in Toronto, Ontario<\/a><\/td>\n<\/tr>\n
SS3.07<\/td>\nReducing Risks While Increasing Sexual Pleasure: The Effects Of The Ph\u00e9nix Program For GbMSM<\/a><\/td>\n<\/tr>\n
SS3.08<\/td>\nSexual Practices among Two-Spirit, Gay, Bisexual, and Queer Men of Different HIV Statuses in Manitoba<\/a><\/td>\n<\/tr>\n
SS4.01<\/td>\nExamining land-based and Indigenous approaches to HIV and STI prevention with Northern and Indigenous Young Women in the Northwest Territories<\/a><\/td>\n<\/tr>\n
SS4.02<\/td>\nMapping the Journey: Developing Culturally Appropriate, Geographically-responsive HIV Care for Northern Manitoba First Nations People<\/a><\/td>\n<\/tr>\n
SS4.05<\/td>\nCreating a M\u00e9tis-specific Model of Culturally-Relevant Shared Care for M\u00e9tis Individuals living with or affected by HIV\/STBBI<\/a><\/td>\n<\/tr>\n
SSKP2.02<\/td>\nEvaluating Dried Blood Spot Testing from a M\u00e9tis Community Perspective<\/a><\/td>\n<\/tr>\n
SSP1.01<\/td>\nUsing Text Mining to Evaluate Quality of Free-Text Health Goals in People with HIV: Proof-of-Concept<\/a><\/td>\n<\/tr>\n
SSP1.02<\/td>\nAn Affirmative Coping Skills Intervention to Improve Mental and Sexual Health of Sexual and Gender Minority Youth (Youth AFFIRM): Interim Results of an Implementation Study<\/a><\/td>\n<\/tr>\n
SSP2.01<\/td>\nLong-overdue and still deficient: the Correctional Service Canada\u2019s Prison Needle Exchange Program<\/a><\/td>\n<\/tr>\n
SSP2.02<\/td>\nA time of vulnerability: People who use substances\u2019 emotional lives and substance use when unable to access or stay in addiction treatment<\/a><\/td>\n<\/tr>\n
SSP2.03<\/td>\nPerspectives of People Living with HIV Regarding the Feasibility and Desirability of Implementing Supervised Injection Services in a Speciality HIV Hospital<\/a><\/td>\n<\/tr>\n
SSP2.04<\/td>\nSupervised Consumption Services Design: a Scoping Review of Stakeholder Opinions<\/a><\/td>\n<\/tr>\n
SSP4.01<\/td>\nBuilding Community Capacity in Affirmative Cognitive Behavioural Therapy for Sexual and Gender Minority Youth: Effectiveness of AFFIRM Facilitator Training<\/a><\/td>\n<\/tr>\n
SSP4.02<\/td>\nCommunity Engagement in HIV Research: Lessons Learned from Four Studies<\/a><\/td>\n<\/tr>\n
SSP4.05<\/td>\nBeyond Mending Bridges: Decolonising Research Structures Through Co-creating Respectful and Equitable Indigenous-Settler PLHIV Partnerships<\/a><\/td>\n<\/tr>\n
SSP4.06<\/td>\nEmbodied and Evolving Indigenous HIV Leadership: An Example from GIPA Homefire<\/a><\/td>\n<\/tr>\n
SSP4.07<\/td>\nIdentifying the Value of Peer Support by Bringing Community Based Research To Our Work With Positive Women in Toronto<\/a><\/td>\n<\/tr>\n
SSP4.08<\/td>\nCo-designing care improvements for women living with HIV: a deliberative dialogue workshop in Montr\u00e9al, Qu\u00e9bec.<\/a><\/td>\n<\/tr>\n
SSP4.12<\/td>\nThe Role of Peer Research Associates in Collecting Complete Data in Longitudinal Health Surveys<\/a><\/td>\n<\/tr>\n
SSP5.01<\/td>\nWhat is the role of sub-cultural identification in the sexual lives of gay, bisexual, and other men who have sex with men?<\/a><\/td>\n<\/tr>\n
SSP5.02<\/td>\nPsychosocial predictors of crystal methamphetamine use among gay, bisexual and other men who have sex with men (gbMSM): The importance of depression and cognitive escape<\/a><\/td>\n<\/tr>\n
SSP5.04<\/td>\nSubstance Use in Syndemic Conditions: Substance Use Stigma and the Mental Health of Sexual Minority Men<\/a><\/td>\n<\/tr>\n
SSP5.05<\/td>\nBarriers and facilitators to PrEP use in Barbados among gbMSM<\/a><\/td>\n<\/tr>\n
SSP5.06<\/td>\nDouble Minority: Childhood Maltreatment and Psychological Distress among Immigrant Gay, Bisexual and Other Men who have Sex with Men in Toronto<\/a><\/td>\n<\/tr>\n
SSP6.01<\/td>\nRe-thinking current policy: Challenging social structures surrounding mandatory HIV screening during the Canadian Immigration Medical Examination (IME)<\/a><\/td>\n<\/tr>\n
SSP7.01<\/td>\nPositive Outlook Workshop: Supporting the Well-Being of Those Working With People Living With HIV<\/a><\/td>\n<\/tr>\n
SSP7.05<\/td>\nThe \u201cWeaving Our Wisdoms\u201d Study, a Positive Action Initiative to Support Indigenous People Living with HIV and AIDS: Findings from a Gathering on the Land<\/a><\/td>\n<\/tr>\n
SSP7.06<\/td>\n\u201cMy heart\u2019s full. My spirit\u2019s flying\u201d: Creating a CHIWOS-PAW Gathering for Indigenous Women Living with HIV in the Coast Salish Territories<\/a><\/td>\n<\/tr>\n
SSP7.08<\/td>\nUsing a Two-Eyed Seeing Approach to Realist Evaluation in a Community-Based Research Project<\/a><\/td>\n<\/tr>\n
SSP7.09<\/td>\nKotawe (start a fire): Igniting cultural responsiveness through community-determined intervention research<\/a><\/td>\n<\/tr>\n
SSP8.01<\/td>\nVulnerability and Resilience: the Lived Experience of Women Who Receive an HIV Diagnosis During the Resettlement Process<\/a><\/td>\n<\/tr>\n
SSP8.02<\/td>\nClients Drive the Supplementary Food Program for HIV+ Community<\/a><\/td>\n<\/tr>\n
SSP8.03<\/td>\nFactors Associated with Willingness to Participate in End-of-Life Cure Research: Perspectives from People Living with HIV<\/a><\/td>\n<\/tr>\n
SSP8.04<\/td>\nDiet Quality, Cardiovascular Disease Risk Factors and Diabetes Prevalence Among Canadians Living with HIV Engaged in a Study About Health Behaviors<\/a><\/td>\n<\/tr>\n
SSP8.07<\/td>\nA Provincial Overview of Community-Based Organizational Supports for Older Adults Living with HIV in British Columbia<\/a><\/td>\n<\/tr>\n
SSP8.08<\/td>\nShortening the HIV Disability Questionnaire (HDQ) for use in Clinical Practice: A Rasch Analysis<\/a><\/td>\n<\/tr>\n
SSP8.09<\/td>\nAcc\u00e8s aux soins dentaires pour les personnes vivant avec le VIH (PVVIH) : Aper\u00e7u de la situation au Qu\u00e9bec en 2019<\/a><\/td>\n<\/tr>\n
SSP8.10<\/td>\nImpact of Health Risks and Protective Factors on Dimensions of Stigma and Overall Health in People Living with HIV: Results from the Ontario HIV Stigma Index<\/a><\/td>\n<\/tr>\n
SSP8.11<\/td>\nDesire for place attachment in healthcare among people living with HIV: Perspectives of potential clients of a forthcoming day health program in a specialty HIV hospital<\/a><\/td>\n<\/tr>\n
SSP8.12<\/td>\nCommunity Connectedness and Correlates of ART Interruptions Among HIV-Positive gbMSM in Vancouver<\/a><\/td>\n<\/tr>\n
SSP8.13<\/td>\nA Sip of C.A.R.E. for Marginalized East and Southeast Asian Communities in Toronto<\/a><\/td>\n<\/tr>\n
SSP8.14<\/td>\nThe Desire to Leave a Financial Legacy \u2013 Life Insurance and People Living with HIV in Canada<\/a><\/td>\n<\/tr>\n
SSP9.01<\/td>\nCommunity pharmacist-facilitated HIV PrEP and hepatitis C treatment in Ontario<\/a><\/td>\n<\/tr>\n
SSP9.02<\/td>\nReducing Barriers Through Atlantic Canada\u2019s First Overdose Prevention Site (OPS)<\/a><\/td>\n<\/tr>\n
SSP9.03<\/td>\nKeeping Secrets or Disclosing Health Information?: Accounting for Women\u2019s Concerns about HIV Disclosure in Maternity Care<\/a><\/td>\n<\/tr>\n
SSP9.04<\/td>\nMeeting People Where They\u2019re At; Helping Them to Get Where They Want To Go: A case study of harm reduction nursing care and cross-agency collaboration<\/a><\/td>\n<\/tr>\n
SSP9.07<\/td>\nPr\u00e9lib: evaluating a newly launched Canadian provider of innovative internet-based services for self-directed HIV and STI screening<\/a><\/td>\n<\/tr>\n
SSP9.08<\/td>\nImplementing Physiotherapy in an HIV Community-Based Care Setting: a Qualitative Study of Perspectives from People Living with HIV and Health Care Providers<\/a><\/td>\n<\/tr>\n
SSP10.02<\/td>\nTreatment Needs, Aspirations, and Polypharmacy: a Positive Perspective Among Persons Living with HIV in Canada<\/a><\/td>\n<\/tr>\n
SSP11.01<\/td>\nHIV and Physical Activity – Actively Working Together to Make a Change<\/a><\/td>\n<\/tr>\n
SSP11.02<\/td>\nThe CanCURE Post-mortem HIV Tissue Biobank: Working Together Towards an HIV Cure<\/a><\/td>\n<\/tr>\n
SSP11.03<\/td>\nProject PEER: Uncovering the Impact of GIPA\/MEPA and the Wise Practices of Informal and Formal Supports<\/a><\/td>\n<\/tr>\n
SSP11.04<\/td>\nChallenges to Accessing Drug Addiction Treatment: the Perspectives of People Who Use Substances Living in Atlantic Canada<\/a><\/td>\n<\/tr>\n
SSP11.05<\/td>\nGetCheckedOnline Ontario?: Exploring Digital STI Testing in a Context of Political-Economic Complexity<\/a><\/td>\n<\/tr>\n
SSP13.01<\/td>\nLoneliness, Social Support, and Sexual Health Behaviours Among Gay, Bisexual, and Other Men who Have Sex with Men (GBM)<\/a><\/td>\n<\/tr>\n
SSP14.03<\/td>\nSociopolitical Contexts of Health and HIV Vulnerability among Heterosexual African Caribbean and Black (ACB) Men in Ottawa<\/a><\/td>\n<\/tr>\n
SSP14.04<\/td>\nUndoing the Unseen: Stigma and its reduction among African, Caribbean, and Black Women Living with HIV in Ontario<\/a><\/td>\n<\/tr>\n
SSP14.05<\/td>\nThe Dangers of Mass Media and Pop Culture in Relation to HIV Vulnerability: a Case Study of Young African, Caribbean and Black Canadian (ACB) Men in Windsor, Ontario<\/a><\/td>\n<\/tr>\n
SSP14.06<\/td>\nHIV Vulnerability and Resilience among Heterosexual African, Caribbean and Black (ACB) Men in Windsor, Ontario: a Perspective of Service Providers<\/a><\/td>\n<\/tr>\n
SSP14.07<\/td>\nAfrican, Caribbean and Black (ACB) Women Taking Control over HIV\/AIDS and Sexual Health:\u00a0 A sustainable model for culturally responsive and evidenced based HIV prevention<\/a><\/td>\n<\/tr>\n
SSP15.01<\/td>\nMessaging Transmission: A Qualitative Analysis of Factors in the Uptake of U=U in Canadian Public Health Messaging<\/a><\/td>\n<\/tr>\n
SSP15.02<\/td>\n\u201c1 + 1 = 0 \/ HIV + Effective treatment = 0 sexual transmission\u201d: The process of creating a simple message about U=U without saying U=U in Quebec, Canada<\/a><\/td>\n<\/tr>\n
SSP16.01<\/td>\nAddressing An Unmet Need: Young Women \u226430 Years Living with HIV (Often Overlooked and Highly Vulnerable)<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

POPULATIONS CL\u00c9S<\/h4>\n

 <\/p>\n\n\n\n\n\n\n\n\n\n
KP1.06<\/td>\nThe A\/C Study: a Cross-Sectional Study of HIV Epidemiology Among African, Caribbean and Black People in Ontario<\/a><\/td>\n<\/tr>\n
KP2.05<\/td>\nExploring the Efficacy of FOXY and SMASH Arts-based HIV Prevention strategies with Northern and Indigenous Youth: Implications for tailored HIV Prevention<\/a><\/td>\n<\/tr>\n
KP2.06<\/td>\nHIV Prevention and Care among Indigenous Two-Spirit, Gay, Bisexual, and Queer Men in Manitoba<\/a><\/td>\n<\/tr>\n
KP3.03<\/td>\nSubstance Use Patterns Among Gay, Bisexual and Other Men Who Have Sex with Men in Toronto, Vancouver and Montreal: Results from the Engage Study<\/a><\/td>\n<\/tr>\n
KP3.04<\/td>\nThe Adherence and Community Engagement (ACE) Team- An Inner City Outreach Team Improving Adherence and Linkage to Care for High Barrier Individuals Who Live with HIV<\/a><\/td>\n<\/tr>\n
KP4.03<\/td>\n\u00ab\u00a0Canada\u2019s Got Talent\u00a0\u00bb \u2014 Trans Latinas Ontario (TLO) & Economic Integration Through Employment. A program for HIV+\/- Individuals, HIV Prevention Program, CSSP<\/a><\/td>\n<\/tr>\n
KP4.05<\/td>\nHIV Testing and PrEP Use among Manitoba\u2019s Two-Spirit, Gay, Bisexual, and Queer Men<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n","protected":false},"excerpt":{"rendered":"

Affiches \u00e9lectroniques Cliquez sur le titre du r\u00e9sum\u00e9 pour voir la pr\u00e9sentation de l’affiche \u00e9lectronique. SCIENCES FONDAMENTALES BS1.02 Characterization of Gag mutations in HIV-1 subtype A long-term non-progressors BS1.03 Rates and Patterns of Indels in HIV-1 gp120 Within Hosts BS1.04 Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking BS1.05 ART-treated adults with diagnosed […]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":4,"template":"","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"class_list":["post-11477","virtual_conferences","type-virtual_conferences","status-publish","hentry"],"acf":[],"yoast_head":"\nAffiches – ACRV<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Affiches – ACRV\" \/>\n<meta property=\"og:description\" content=\"Affiches \u00e9lectroniques Cliquez sur le titre du r\u00e9sum\u00e9 pour voir la pr\u00e9sentation de l’affiche \u00e9lectronique. SCIENCES FONDAMENTALES BS1.02 Characterization of Gag mutations in HIV-1 subtype A long-term non-progressors BS1.03 Rates and Patterns of Indels in HIV-1 gp120 Within Hosts BS1.04 Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking BS1.05 ART-treated adults with diagnosed […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/\" \/>\n<meta property=\"og:site_name\" content=\"ACRV\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch\" \/>\n<meta property=\"article:modified_time\" content=\"2020-05-07T17:11:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@CAHR_ACRV\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"24 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/\",\"name\":\"Affiches – ACRV\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/CAHR-2020-Virtual-Banner-1024x279.png\",\"datePublished\":\"2020-04-13T21:43:34+00:00\",\"dateModified\":\"2020-05-07T17:11:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/CAHR-2020-Virtual-Banner-1024x279.png\",\"contentUrl\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/wp-content\\\/uploads\\\/2020\\\/04\\\/CAHR-2020-Virtual-Banner-1024x279.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/virtual-conferences\\\/affiches\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/fr\\\/accueil\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Affiches\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#website\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/\",\"name\":\"ACRV\",\"description\":\"L'association canadienne de recherche sur le VIH\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#organization\",\"name\":\"Canadian Association for HIV Research\",\"alternateName\":\"CAHR\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/cahr-organization-logo.png\",\"contentUrl\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/wp-content\\\/uploads\\\/2025\\\/06\\\/cahr-organization-logo.png\",\"width\":696,\"height\":696,\"caption\":\"Canadian Association for HIV Research\"},\"image\":{\"@id\":\"https:\\\/\\\/www.cahr-acrv.ca\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/CanadianAssociationforHIVResearch\",\"https:\\\/\\\/x.com\\\/CAHR_ACRV\",\"https:\\\/\\\/bsky.app\\\/profile\\\/cahr-acrv.bsky.social\",\"https:\\\/\\\/www.youtube.com\\\/user\\\/CAHRACRV\",\"https:\\\/\\\/www.instagram.com\\\/cahr_acrv\\\/\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/canadian-association-for-hiv-research\\\/\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Affiches – ACRV","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/","og_locale":"fr_FR","og_type":"article","og_title":"Affiches – ACRV","og_description":"Affiches \u00e9lectroniques Cliquez sur le titre du r\u00e9sum\u00e9 pour voir la pr\u00e9sentation de l’affiche \u00e9lectronique. SCIENCES FONDAMENTALES BS1.02 Characterization of Gag mutations in HIV-1 subtype A long-term non-progressors BS1.03 Rates and Patterns of Indels in HIV-1 gp120 Within Hosts BS1.04 Pan-retroviral Nucleocapsid-Mediated Phase Separation Regulates Genomic RNA Positioning and Trafficking BS1.05 ART-treated adults with diagnosed […]","og_url":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/","og_site_name":"ACRV","article_publisher":"https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch","article_modified_time":"2020-05-07T17:11:08+00:00","og_image":[{"url":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_site":"@CAHR_ACRV","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"24 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/","url":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/","name":"Affiches – ACRV","isPartOf":{"@id":"https:\/\/www.cahr-acrv.ca\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/#primaryimage"},"image":{"@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/#primaryimage"},"thumbnailUrl":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png","datePublished":"2020-04-13T21:43:34+00:00","dateModified":"2020-05-07T17:11:08+00:00","breadcrumb":{"@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/#primaryimage","url":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png","contentUrl":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2020\/04\/CAHR-2020-Virtual-Banner-1024x279.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.cahr-acrv.ca\/fr\/virtual-conferences\/affiches\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.cahr-acrv.ca\/fr\/accueil\/"},{"@type":"ListItem","position":2,"name":"Affiches"}]},{"@type":"WebSite","@id":"https:\/\/www.cahr-acrv.ca\/#website","url":"https:\/\/www.cahr-acrv.ca\/","name":"ACRV","description":"L'association canadienne de recherche sur le VIH","publisher":{"@id":"https:\/\/www.cahr-acrv.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.cahr-acrv.ca\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/www.cahr-acrv.ca\/#organization","name":"Canadian Association for HIV Research","alternateName":"CAHR","url":"https:\/\/www.cahr-acrv.ca\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/","url":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png","contentUrl":"https:\/\/www.cahr-acrv.ca\/wp-content\/uploads\/2025\/06\/cahr-organization-logo.png","width":696,"height":696,"caption":"Canadian Association for HIV Research"},"image":{"@id":"https:\/\/www.cahr-acrv.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/CanadianAssociationforHIVResearch","https:\/\/x.com\/CAHR_ACRV","https:\/\/bsky.app\/profile\/cahr-acrv.bsky.social","https:\/\/www.youtube.com\/user\/CAHRACRV","https:\/\/www.instagram.com\/cahr_acrv\/","https:\/\/www.linkedin.com\/company\/canadian-association-for-hiv-research\/"]}]}},"_links":{"self":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/virtual_conferences\/11477","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/virtual_conferences"}],"about":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/types\/virtual_conferences"}],"version-history":[{"count":0,"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/virtual_conferences\/11477\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.cahr-acrv.ca\/fr\/wp-json\/wp\/v2\/media?parent=11477"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}